Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.

Try Elite for Free

K

KLRS

Kalaris Therapeutics Inc

3.05

Sep 18 • 1:26 PM ET -0.11 (-3.48%)

Healthcare Biotechnology USA Micro NASD

Peers: AARD CGTX CNTB KZIA NTHI SPRO VRCA AGEN GALT IMUX

| Held by: VTI VXF IWC BUSM DCOR DFAC

Scroll to Statements

Index	-
Market Cap	66.62M
Enterprise Value	-25.52M
Income	-44.26M
Sales	0.00M
Book/sh	2.42
Cash/sh	4.28
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	20
IPO	Jul 30, 2020

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	1.26
P/C	0.71
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	10.92
Current Ratio	10.92
Debt/Eq	0.02
LT Debt/Eq	0.02
Option/Short	No / Yes

EPS (ttm)	-2.01
EPS next Y	-1.66
EPS next Q	-0.52
EPS this Y	29.56%
EPS next Y	17.37%
EPS next 5Y	5.37%
EPS past 3/5Y	61.69% 45.59%
Sales past 3/5Y	- -
EPS Y/Y TTM	73.44%
Sales Y/Y TTM	-
EPS Q/Q	20.27%
Sales Q/Q	-
Earnings	Aug 11 BMO
EPS/Sales Surpr.	3.03% -

Insider Own	63.69%
Insider Trans	1.77%
Inst Own	19.80%
Inst Trans	-2.22%
ROA	-46.02%
ROE	-79.91%
ROIC	-75.37%
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	-17.60%
SMA50	-21.89%
SMA200	-51.55%
Trades

Shs Outstand	23.80M
Shs Float	8.64M
Short Float	4.00%
Short Ratio	1.37
Short Interest	0.35M
52W High	11.88 -74.33%
52W Low	3.03 0.66%
Volatility	5.07% 6.04%
ATR (14)	0.23
RSI (14)	24.95
Beta	0.41
Rel Volume	0.12
Avg Volume	253.23K
Volume	19,055

Perf Week	-9.76%
Perf Month	-26.86%
Perf Quarter	-35.38%
Perf Half Y	-55.21%
Perf YTD	-63.86%
Perf Year	-30.52%
Perf 3Y	-93.83%
Perf 5Y	-99.45%
Perf 10Y	-
Recom	1.25
Target Price	18.71
Prev Close	3.16
Price	3.05
Change %	-3.48%

Affiliate • Advertise • API and Exports • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Stock quotes delayed by 1 minute. Futures and options delayed by 15 minutes.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)